Detection of myocardial disorders by magnetic resonance spectroscopy

被引:0
|
作者
Lucy E Hudsmith
Stefan Neubauer
机构
[1] LE Hudsmith is a Specialist Registrar in Cardiology at the Queen Elizabeth Hospital,S Neubauer is Professor of Cardiovascular Medicine at the Department of Cardiovascular Medicine
[2] Birmingham and at the John Radcliffe Hospital,undefined
[3] Oxford,undefined
[4] John Radcliffe Hospital,undefined
[5] and is Clinical Director of the University of Oxford Centre for Clinical Magnetic Resonance Research,undefined
[6] Oxford,undefined
[7] UK.,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Magnetic resonance spectroscopy (MRS) utilizes magnetic resonance signals from nuclei, such as phosphorus-31, to provide information regarding the biochemical composition and metabolic state of cardiac muscle. This technique is the only method available for noninvasive assessment of cardiac metabolism without the need for the application of external radioactive tracers. MRS provides insights into the role of cardiac energetics in ischemic heart disease, heart failure, hypertrophy, and valve disease. Furthermore, response to therapeutic intervention can be monitored using this method. At present, this technique is used as a research tool, because low spatial and temporal resolution, as well as low reproducibility, precludes its diagnostic use in clinical practice; however, higher-field magnetic resonance systems—using, for example, 7 T—will enable improvements in resolution and reproducibility that may take cardiac MRS into the clinical realm.
引用
下载
收藏
页码:S49 / S56
相关论文
共 50 条
  • [1] Detection of myocardial disorders by magnetic resonance spectroscopy
    Hudsmith, Lucy E.
    Neubauer, Stefan
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2008, 5 (Suppl 2): : S49 - S56
  • [2] Magnetic Resonance Spectroscopy in Myocardial Disease
    Hudsmith, Lucy E.
    Neubauer, Stefan
    JACC-CARDIOVASCULAR IMAGING, 2009, 2 (01) : 87 - 96
  • [3] Magnetic resonance spectroscopy in myocardial disease
    Beadle, Roger
    Frenneaux, Michael
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (02) : 269 - 277
  • [4] Magnetic resonance spectroscopy in anxiety disorders
    Trzesniak, Clarissa
    Araujo, David
    Crippa, Jose Alexandre S.
    ACTA NEUROPSYCHIATRICA, 2008, 20 (02): : 56 - 71
  • [5] Magnetic Resonance Spectroscopy in Metabolic Disorders
    Rossi, Andrea
    Biancheri, Roberta
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2013, 23 (03) : 425 - +
  • [6] Magnetic resonance spectroscopy in affective disorders
    Reutens, S
    Sachdev, P
    Malhi, G
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2001, 35 (04): : A23 - A23
  • [7] Magnetic resonance spectroscopy in affective disorders
    Kato, T
    Inubushi, T
    Kato, N
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (02) : 133 - 147
  • [8] Nuclear magnetic resonance spectroscopy and genetic disorders
    Iles, R. A.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (01) : 15 - 36
  • [9] Magnetic resonance proton spectroscopy in affective disorders
    Rachel, Wojciech
    Siwek, Marcin
    Dudek, Dominika
    Zieba, Andrzej
    Werewka-Maczuga, Agnieszka
    Herman-Sucharska, Izabela
    Urbanik, Andrzej
    NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA, 2008, 3 (01): : 29 - 36
  • [10] Measuring Myocardial Energetics with Cardiovascular Magnetic Resonance Spectroscopy
    Sourdon, Joevin
    Lewsey, Sabra C.
    Schar, Michael
    Weiss, Robert G.
    HEART FAILURE CLINICS, 2021, 17 (01) : 149 - 156